Loading…
Oruka Therapeutics, Inc. is projected to rise to $120.55 by 2027, a +23% move from its current price of $97.86. ORKA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $94.07 | $97.81 | $101.70 | -0.05% |
| Aug 2 | $92.51 | $97.76 | $103.31 | -0.10% |
| Aug 3 | $91.32 | $97.71 | $104.54 | -0.15% |
| Aug 4 | $90.33 | $97.66 | $105.59 | -0.21% |
| Aug 5 | $89.45 | $97.61 | $106.51 | -0.26% |
| Aug 6 | $88.67 | $97.56 | $107.34 | -0.31% |
| Aug 7 | $87.94 | $97.51 | $108.11 | -0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $87.94 | $97.51 | $108.11 | -0.36% |
| Week 2 | $83.96 | $97.16 | $112.43 | -0.72% |
| Week 3 | $80.96 | $96.81 | $115.76 | -1.07% |
| Week 4 | $78.47 | $96.46 | $118.58 | -1.43% |
| Week 5 | $76.30 | $96.11 | $121.07 | -1.78% |
| Week 6 | $74.37 | $95.77 | $123.32 | -2.14% |
| Week 7 | $72.62 | $95.42 | $125.39 | -2.49% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oruka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology indications. Its lead products include ORKA-001, which targets the p19 subunit of interleukin-23 and is in phase 2a trial for PsO; and ORKA-002, which targets interleukin-17A and interleukin-17F, in phase 2 trial for PsO, psoriatic arthritis, and other conditions.
The company also develops ORKA-003 for targeting an undisclosed pathway, and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. It is headquartered in Menlo Park, California, and is categorized in Healthcare.
ORKA Therapeutics, Inc. is currently priced at $92.70 with a market capitalization of $5.59B and a rank of 1246. The near-term price picture shows a generally flat to rising path, with a 30-day range between $70.47 and $121.95 and a support/resistance framework at $60.14 and $95.17, respectively.
A major floor 59.2% below — a decisive break under it would weaken the trend.
The nearest floor, 27.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 18.4% above — clearing it would confirm fresh momentum.
Key ORKA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ORKA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $91.75 | Buy | $92.63 | Buy |
| MA 10 | $92.19 | Buy | $91.39 | Buy |
| MA 20 | $88.80 | Buy | $88.80 | Buy |
| MA 50 | $77.18 | Buy | $80.17 | Buy |
| MA 100 | $66.85 | Buy | $68.81 | Buy |
| MA 200 | $48.66 | Buy | $54.34 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.84 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 174.12 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.34 | Sell |
| ROC (12) | 11.88 | Buy |
| Bollinger %B (20,2) | 1.07 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.78 | Buy |
| Awesome (5,34) | 6.36 | Buy |
| Ultimate (7,14,28) | 62.01 | Neutral |
| Momentum (10) | 14.82 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 91.10 | Buy |
| ADX (14) | 22.43 | Buy |
| ATR (14) | 2.89 | Info |
The 30-day technical picture is bullish overall. RSI14 is 60, suggesting neutral-leaning bullish momentum. The stock is trading above the SMA50 of $72.12 and well above the SMA200 of $45.47, signaling an upward trend.
The 30-day range runs from a low of $70.47 to a high of $121.95. Key support is at $60.14 and resistance at $95.17, providing defined levels for upside and downside in the near term. The asset exhibits high volatility, reflected in an annualized volatility of 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $26.40 | $97.86 | $123.88 | 0% | Neutral | |
| $92.38 | $120.55 | $168.41 | +23% | Bullish | |
| $95.92 | $130.58 | $191.89 | +33% | Bullish | |
| $92.44 | $130.36 | $199.17 | +33% | Bullish | |
| $130.76 | $190.32 | $300.34 | +94% | Bullish | |
| $162.22 | $243.04 | $394.44 | +148% | Bullish | |
| $170.05 | $261.81 | $435.63 | +168% | Bullish | |
| $183.41 | $289.75 | $493.07 | +196% | Bullish | |
| $176.89 | $286.44 | $497.56 | +193% | Bullish | |
| $194.21 | $322.08 | $570.19 | +229% | Bullish | |
| $293.73 | $544.34 | $1,042.51 | +456% | Bullish | |
| $573.89 | $1,275.31 | $2,732.57 | +12.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $26.40 | $97.86 | $114.32 | +0.00% |
| August 2026 | $79.15 | $93.74 | $114.23 | -4.21% |
| September 2026 | $77.90 | $93.38 | $115.95 | -0.39% |
| October 2026 | $80.04 | $96.88 | $122.08 | +3.75% |
| November 2026 | $79.25 | $96.70 | $123.32 | -0.18% |
| December 2026 | $78.18 | $96.10 | $123.88 | -0.62% |
Click any year to see its month-by-month ORKA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Oruka Therapeutics, Inc.'s 2026 outlook centres on $97.86, within a $26.40 to $123.88 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ORKA could reach as high as $168.41, with a base case around $120.55 and support toward $92.38 — roughly +23% from $97.86. Buyers look set to stay in control over this stretch.
Expect ORKA to range from $95.92 to $191.89 through 2028. The $130.58 average target implies a +33% move from current prices. That is up +8% on the projected 2027 average. Momentum favours further upside here.
The ORKA price prediction for 2029 points to an average of $130.36 (low $92.44, high $199.17) — a potential gain of +33% on today's $97.86. Buyers look set to stay in control over this stretch.
In 2030, ORKA is projected to trade between $130.76 and $300.34, averaging $190.32 — a potential gain of +94% from today's $97.86. That is up +46% on the projected 2029 average. Momentum favours further upside here.
Oruka Therapeutics, Inc.'s 2031 outlook centres on $243.04, within a $162.22 to $394.44 range. That is up +28% on the projected 2030 average. That marks a +148% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ORKA could reach as high as $435.63, with a base case around $261.81 and support toward $170.05 — roughly +168% from $97.86. Momentum favours further upside here.
Expect ORKA to range from $183.41 to $493.07 through 2033. The $289.75 average target implies a +196% move from current prices. That is up +11% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ORKA price prediction for 2034 points to an average of $286.44 (low $176.89, high $497.56) — a potential gain of +193% on today's $97.86. Momentum favours further upside here.
In 2035, ORKA is projected to trade between $194.21 and $570.19, averaging $322.08 — a potential gain of +229% from today's $97.86. That is up +12% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Oruka Therapeutics, Inc.'s 2040 outlook centres on $544.34, within a $293.73 to $1,042.51 range. That is up +69% on the projected 2035 average. That marks a +456% change versus current levels. Momentum favours further upside here.
By 2050, ORKA could reach as high as $2,732.57, with a base case around $1,275.31 and support toward $573.89 — roughly +12.0x from $97.86. Buyers look set to stay in control over this stretch.
Investing $1,000 in ORKA today (≈ 10.21868 ORKA) could be worth
$13,031.95
+$12,031.95 (+1203%) by 2050 · US Dollar
Based on the average projected ORKA price of $1,275.31 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ORKAwould be worth at today's price.
$1,000 invested in ORKA on Jul 30, 2025 (≈ 72.516316 ORKA) would be worth
$7,096.45
+$6,096.45 (+609.6%) today · 7.10× · US Dollar
Based on a ORKA entry price of $13.79 vs. today's $97.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $91.95 | $1,064.27 | +6.4% |
| 1 month ago | $95.17 | $1,028.27 | +2.8% |
| 3 months ago | $62.58 | $1,563.76 | +56.4% |
| 6 months ago | $34.23 | $2,858.9 | +185.9% |
| 1 year ago | $13.79 | $7,096.45 | +609.6% |
| All time (5.0y) ago | $38.28 | $2,556.43 | +155.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ORKA forecast.
Our base-case forecast reaches $200.00 around 2031.
Implied market cap at $200.00: $12.06B
Over the multi-year horizon, the forecast shows a rising average price from a 2026 baseline of $92.70 with a 0% ROI, into a bullish multi-year trajectory. The 2030 average is $182.78 with a 97.2% ROI, and the sentiment remains bullish. By 2040, the average is projected at $487.16 with a 425.5% ROI, still bullish.
The 2050 forecast extends to an average of $1,207.68 with a 1,202.8% ROI, continuing bullish sentiment. These figures imply substantial long-run upside, but they are estimates and not guarantees, with notable volatility and uncertainty over any forward path.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $182.78, a min of $123.22, a max of $293.83, and a ROI of 97.2%, with bullish sentiment.
Forecasts show bullish sentiment from 2027 onward, with rising averages and ROI up to 1,202.8% by 2050 (avg $1,207.68; max $2,667.19). The 2026 outlook is neutral with an average of $92.70 and ROI of 0%.
Yes. The 2026 forecast lists a max of $120.01 and an average of $92.70.
The 2050 forecast shows an average price of $1,207.68, a min of $543.46, a max of $2,667.19, and a ROI of 1,202.8%, with bullish sentiment.
Current price is $92.70 and market capitalization is $5.59B.
Oruka Therapeutics, Inc. Community Discussion
0Share your Oruka Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.